Efficacy and safety of MCLA-129, an anti-EGFR/c-MET bispecific antibody, in head and neck squamous cell cancer (HNSCC)

被引：0

作者：

Bossi, P. ^{[1
]}

Minuti, G. ^{[2
]}

Brana, I. ^{[3
]}

Garcia, V. Moreno ^{[4
]}

Boni, V. ^{[5
]}

Jamme, P. ^{[6
]}

Call, J. A. ^{[7
]}

Yan, C. ^{[8
]}

Barasa, B. ^{[9
]}

Doze, P. ^{[10
]}

Joe, A. K. ^{[11
]}

Laus, G. ^{[11
]}

Daste, A. ^{[12
]}

机构：

[1] IRCCS Humanitas Res Hosp, Med Oncol, Milan, Italy

[2] IRCCS Ist Nazl Tumori Regina Elena IRE, Phase & Precis Med Unit 1, Rome, Italy

[3] Vall Hebron Univ Hosp, Thorac Canc Unit, Barcelona, Spain

[4] Hosp Univ Fdn Jimenez Diaz, START Madrid, FJD Early Phase Clin Trials Unit, Madrid, Spain

[5] Hosp Univ Quironsalud Madrid, Oncol Dept, Pozuelo De Alarcon, Spain

[6] CHU Lille, Haut France, Ctr Hosp Reg Univ Lille, Lille, France

[7] South Texas Accelerated Res Therapeut START, Phase & Trials, San Antonio, TX USA

[8] Merus NV, Biostat, Utrecht, Netherlands

[9] Merus NV, Translat Res, Utrecht, Netherlands

[10] Merus NV, Clin Operat, Utrecht, Netherlands

[11] Merus NV, Clin Dev, Utrecht, Netherlands

[12] CHU Bordeaux, Hop St Andre, Med Oncol, Bordeaux, France

来源：

ANNALS OF ONCOLOGY | 2023年 / 34卷

关键词：

D O I：

10.1016/j.annonc.2023.10.470

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

362P

引用

页码：S1610 / S1611

页数：2

共 50 条

[21] Anti-EGFR targeted therapy for squamos cell head and neck cancer
Kawecki, Andrzej
ONCOLOGY IN CLINICAL PRACTICE, 2010, 6 (05): : 264 - 271
[22] Efficacy and safety of a novel anti-EGFR ADC MRG003 in recurrent or metastatic squamous cell carcinoma of the head and neck patients
Xue, L.
Han, Y.
Zhang, Q.
Li, X.
Fang, M.
Zhong, L.
Wang, S.
Liu, Y.
Zhang, S.
Guo, Y.
ANNALS OF ONCOLOGY, 2023, 34 : S590 - S590
[23] c-Met as a Target for Radiation Enhancement in Head and Neck Squamous Cell Carcinomas
Baschnagel, A. M.
Galoforo, S.
Thibodeau, B. J.
Ahmed, S.
Akervall, J.
George, W. D.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 87 (02): : S649 - S650
[24] Effect of c-Met expression on survival in head and neck squamous cell carcinoma
Lo Muzio, Lorenzo
Farina, Antonio
Rubini, Corrado
Coccia, Erminia
Capogreco, Mario
Colella, Giuseppe
Leonardi, Rosalia
Campisi, Giuseppina
Carinci, Francesco
TUMOR BIOLOGY, 2006, 27 (03) : 115 - 121
[25] Radiosensitization by an anti-EGFR single chain antibody in human head and neck cancer cells
Bonner, J.
Trummell, H. Q.
Sanford, L. L.
Raisch, K. P.
RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S32 - S33
[26] Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis
Vit Vsiansky
Jaromir Gumulec
Martina Raudenska
Michal Masarik
Scientific Reports, 8
[27] Prognostic role of c-Met in head and neck squamous cell cancer tissues: a meta-analysis
Vsiansky, Vit
Gumulec, Jaromir
Raudenska, Martina
Masarik, Michal
SCIENTIFIC REPORTS, 2018, 8
[28] Targeting pathways mediating resistance to anti-EGFR therapy in squamous cell carcinoma of the head and neck
Campbell, Nicholas P.
Hensing, Thomas A.
Bhayani, Mihir K.
Shaikh, Arif Y.
Brockstein, Bruce E.
EXPERT REVIEW OF ANTICANCER THERAPY, 2016, 16 (08) : 847 - 858
[29] Affinity of yttrium-90 labeled anti-EGFR antibody cetuximab to head and neck squamous cell carcinoma (HNSCC) xenografts, compared to the response to combined external and internal irradiation
Sihver, Wiebke
Koi, Lydia
Bruechner, Kerstin
Heldt, Jan-Martin
Bergmann, Ralf
Pietzsch, Hans-Juergen
Pietzsch, Jens
Steinbach, Joerg
Zips, Daniel
Baumann, Michael
JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2013, 56 : S41 - S41
[30] A proof of concept trial of the anti-EGFR antibody mixture Sym004 in patients with squamous cell carcinoma of the head and neck
Machiels, J. -P.
Specenier, P.
Krauss, J.
Dietz, A.
Kaminsky, M. -C.
Lalami, Y.
Henke, M.
Keilholz, U.
Knecht, R.
Skartved, N. J.
Horak, I. D.
Pamperin, P.
Braun, S.
Gauler, T. C.
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2015, 76 (01) : 13 - 20

← 1 2 3 4 5 →